242 related articles for article (PubMed ID: 32185430)
1. [Pityriasis rubra pilaris : Successful treatment with ixekizumab].
Kohn D; Wetzig T
Hautarzt; 2020 Aug; 71(8):624-626. PubMed ID: 32185430
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin.
Chastagner M; Hoelt P; Kanitakis J; Jullien D; Villani AP
Eur J Dermatol; 2019 Apr; 29(2):218-220. PubMed ID: 30827945
[No Abstract] [Full Text] [Related]
4. Successful treatment of Pityriasis rubra pilaris with brodalumab.
De Rosa A; Gambardella A; Licata G; Alfano R; Argenziano G
Australas J Dermatol; 2020 May; 61(2):e249-e251. PubMed ID: 31851372
[No Abstract] [Full Text] [Related]
5. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
[TBL] [Abstract][Full Text] [Related]
6. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?
Ivanova K; Itin P; Haeusermann P
Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
Boyd AH; Polcari IC
Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
[TBL] [Abstract][Full Text] [Related]
8. [Pityriasis rubra pilaris].
Wollina U
Hautarzt; 2012 Aug; 63(8):655-61; quiz 662. PubMed ID: 22825756
[TBL] [Abstract][Full Text] [Related]
9. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.
Eytan O; Sarig O; Sprecher E; van Steensel MA
Br J Dermatol; 2014 Aug; 171(2):420-2. PubMed ID: 24641799
[No Abstract] [Full Text] [Related]
10. Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series.
Pham JP; Allen N; Smith A
Australas J Dermatol; 2022 Nov; 63(4):522-524. PubMed ID: 36129444
[No Abstract] [Full Text] [Related]
11. Pityriasis rubra pilaris successfully treated with adalimumab.
Schreml S; Zeller V; Babilas P; Karrer S; Landthaler M; Szeimies RM
Clin Exp Dermatol; 2010 Oct; 35(7):792-3. PubMed ID: 20345992
[No Abstract] [Full Text] [Related]
12. Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatment.
O'Kane D; Devereux CE; Walsh MY; Hoey SE
Clin Exp Dermatol; 2010 Jun; 35(4):e155-6. PubMed ID: 19925485
[No Abstract] [Full Text] [Related]
13. Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris?
Balestri R; Bardazzi F; Antonucci A
Br J Dermatol; 2010 Oct; 163(4):896-7; author reply 897-8. PubMed ID: 20662839
[No Abstract] [Full Text] [Related]
14. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
Boudreaux BW; Pincelli TP; Bhullar PK; Patel MH; Brumfiel CM; Li X; Heckman MG; Pittelkow MR; Mangold AR; Sluzevich JC
Br J Dermatol; 2022 Nov; 187(5):650-658. PubMed ID: 35701384
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
Wassef C; Lombardi A; Rao BK
Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
[TBL] [Abstract][Full Text] [Related]
16. Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review.
Chandy RJ; Chokshi A; Tan I; Feldman SR
J Cutan Med Surg; 2024; 28(3):269-275. PubMed ID: 38549359
[TBL] [Abstract][Full Text] [Related]
17. Role of IL-23 inhibitors including risankizumab and guselkumab in the treatment of pityriasis rubra pilaris.
Rahman SM; Ahmed F; Haque A
Arch Dermatol Res; 2024 Jun; 316(6):334. PubMed ID: 38844710
[TBL] [Abstract][Full Text] [Related]
18. A case of resistant pityriasis ribra pilaris responsive to combination acitrentin and ustekinumab.
Cook E; Tran KW; Kollipara S; Tarbox M; Akin R
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609453
[TBL] [Abstract][Full Text] [Related]
19. Acute juvenile pityriasis rubra pilaris: a case report after mononucleosis infection.
Betto P; Vassilopoulou A; Colombari R; Veller-Fornasa C
G Ital Dermatol Venereol; 2008 Aug; 143(4):271-3. PubMed ID: 18833084
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapies of pityriasis rubra pilaris: a systematic review.
Kromer C; Sabat R; Celis D; Mössner R
J Dtsch Dermatol Ges; 2019 Mar; 17(3):243-259. PubMed ID: 30520557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
